questionText: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the impact of high launch prices set by major pharmaceutical firms on NICE’s cost-effectiveness assessments; and what steps are being taken to prevent suc
answerText: The National Institute for Health and Care Excellence (NICE) makes recommendations on whether all new medicines should be routinely funded by the National Health Service based on an assessment of clinical and cost effectiveness. The NHS in England is lega...
heading: Drugs: Prices